1. Boldt J, Suttner S. Plasma substitutes. Minerva Anestesiol 2005;71:741-758.
2. Bai SJ, Lee JW, Lee KY. Fluid therapy: classification and characteristics of intravenous fluids. J Korean Med Assoc 2010;53:1103-1112.
3. Vaupshas HJ, Levy M. Distribution of saline following acute volume loading: postural effects. Clin Invest Med 1990;13:165-177.
4. Imm A, Carlson RW. Fluid resuscitation in circulatory shock. Crit Care Clin 1993;9:313-333.
6. Caraceni P, Domenicali M, Tovoli A, Napoli L, Ricci CS, Tufoni M, Bernardi M. Clinical indications for the albumin use: still a controversial issue. Eur J Intern Med 2013;06. 20. [Epub]. DOI:
10.1016/j.ejim.2013.05.015.
7. Soni N, Margarson M. Use and abuse of albumin in clinical practice. Anasthesiol Intensivmed Notfallmed Schmerzther 1999;34:784-788.
8. Garcia-Martinez R, Caraceni P, Bernardi M, Gines P, Arroyo V, Jalan R. Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology 2013;02. 19. [Epub]. DOI:
10.1002/hep.26338.
10. Guthrie RD Jr, Hines C Jr. Use of intravenous albumin in the critically ill patient. Am J Gastroenterol 1991;86:255-263.
11. Koppel C, Baudisch H, Ibe K. Inadvertent metal loading of critically ill patients with acute renal failure by human albumin solution infusion therapy. J Toxicol Clin Toxicol 1988;26:337-356.
12. Alving BM, Hojima Y, Pisano JJ, Mason BL, Buckingham RE Jr, Mozen MM, Finlayson JS. Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction. N Engl J Med 1978;299:66-70.
13. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-2256.
14. De Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 2001;29:1261-1267.
15. Raghunath V, Marshall G, Ratanjee SK, Francis RS. Transient massive proteinuria after gelatin-derived plasma expander (Gelofusine®) administration. Nephrology (Carlton) 2013;18:240-241.
16. Kathirvel S, Podder S, Batra YK, Malhotra N, Mahajan R. Severe life threatening reaction to Haemaccel in a patient with bronchial asthma. Eur J Anaesthesiol 2001;18:122-123.
17. Menger MD, Sack FU, Hammersen F, Messmer K. Tissue oxygenation after prolonged ischemia in skeletal muscle: therapeutic effect of prophylactic isovolemic hemodilution. Adv Exp Med Biol 1989;248:387-395.
18. Lee J. Plasma volume expanders and intraoperative fluid therapy. Korean J Anesthesiol 2009;56:483-491.
19. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005;44:681-699.
20. Boldt J. Modern rapidly degradable hydroxyethyl starches: current concepts. Anesth Analg 2009;108:1574-1582.
21. Haisch G, Boldt J, Krebs C, Suttner S, Lehmann A, Isgro F. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth 2001;15:316-321.
22. Kim KO, Han SS, Kim CS. Effects of intravascular volume therapy with a hydroxyethyl starch (HES 130/0.4) on blood coagulation in children undergoing cardiac surgery. Korean J Anesthesiol 2004;47:379-384.
23. Na S, Nam SB, Kim DH, Shim JK, Yang HG, Kwak YL. Effect of preoperative volume loading with new hydroxyethyl starch (6% HES 130/0.4) in patients undergoing off-pump coronary artery bypass graft surgery. Korean J Anesthesiol 2006;51:669-674.
24. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 2001;72:527-533.
25. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999;25:258-268.
26. Wiedermann CJ, Dunzendorfer S, Gaioni LU, Zaraca F, Joannidis M. Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care 2010;14:R191.
27. Boussekey N, Darmon R, Langlois J, Alfandari S, Devos P, Meybeck A, Chiche A, Georges H, Leroy O. Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury. Crit Care 2010;14:R40.
28. Hartog CS, Bauer M, Reinhart K. The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg 2011;112:156-164.